Certified by Founder Lodge
Cellarity
United States - Cambridge, Massachusetts
START UP
1 Disclosed Funding Rounds $121,000,000
0 Participating Investments
-
Founded date
2017
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Founded by Flagship Pioneering, Cellarity is the first company developing medicines through an understanding of cell behaviors. The company’s broad platform harnesses single-cell technologies
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 04 ,2022 | Series C | $121,000,000 |
Hanwha Impact Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Bitreport | $316,823 | (Nov 19, 2024)
SuperAnnotate | $36,000,000 | (Nov 19, 2024)
Plantible | $30,000,000 | (Nov 19, 2024)
ANELLO Photonics | Undisclosed Amount | (Nov 19, 2024)
Bluespine | $7,200,000 | (Nov 19, 2024)
